CLINICAL_TRIALS
trial_result
· 2024-10-17
Clinical Trial Update: Phase 2 Study of VGT-309 in Lung Cancer [Phase 2]
Summary
Phase 2 study results for VGT-309 in lung cancer have been posted following completion of the trial.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vergent Bioscience, Inc. | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-10-17